WINDTREE THERAPEUTICS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch WINT and buy or sell other stocks, ETFs, and their options commission-free!

About WINT

Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. 

CEO
Craig E. Fraser
CEOCraig E. Fraser
Employees
32
Employees32
Headquarters
Warrington, Pennsylvania
HeadquartersWarrington, Pennsylvania
Founded
1992
Founded1992
Employees
32
Employees32

WINT Key Statistics

Market cap
14.86M
Market cap14.86M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
796.60
Average volume796.60
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$44.91
52 Week high$44.91
52 Week low
$3.30
52 Week low$3.30

Stock Snapshot

The current WINDTREE THERAPEUTICS(WINT) stock price is $1.09, with a market capitalization of 14.86M.

During the trading day, WINDTREE THERAPEUTICS(WINT) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 796.6.

The stock's 52-week range extends from a low of $3.30 to a high of $44.91.

The stock's 52-week range extends from a low of $3.30 to a high of $44.91.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.